High incidence of multidrug-resistant organisms and modifiable risk factors associated with surgical site infections: a cohort study in a tertiary medical center in Kuala Lumpur, Malaysia from 2020 to 2023
- PMID: 40082971
- PMCID: PMC11907968
- DOI: 10.1186/s13756-025-01537-2
High incidence of multidrug-resistant organisms and modifiable risk factors associated with surgical site infections: a cohort study in a tertiary medical center in Kuala Lumpur, Malaysia from 2020 to 2023
Abstract
Background: Surgical site infections (SSIs) are a persistent challenge in healthcare, contributing significantly to patient morbidity, mortality, and healthcare costs. Despite advancements in preventive measures, SSIs remain prevalent, especially in countries like Malaysia where rates are higher than in high-income nations.
Methods: A prospective, cohort study was conducted at the University Malaya Medical Center (UMMC), Malaysia, from November 2020 to May 2023. Clinical and microbiological data were collected, and logistic regression were performed to identify risk factors associated with SSIs.
Results: A total of 1,815 patients undergoing orthopedic, neurosurgical, and general surgical procedures were monitored for SSIs. The incidence rate of SSIs was 3.23 per 100 procedures (n = 71) with significant associations observed between SSI occurrence and prolonged surgical duration > 100 min, extended hospitalization > 5 days, trauma-to-surgery interval > 8 days, and presence of implants. Common pathogens isolated included Staphylococcus aureus, Klebsiella pneumoniae, and Pseudomonas aeruginosa. Multidrug-resistant organisms (MDROs) were identified in 42.1% of the total isolates.
Conclusions: In this study, a high rate of MDRO and risk factors for SSI were identified. It emphasises the need for ongoing surveillance to guide infection prevention strategies and antimicrobial stewardship programs. Future research should prioritize evaluating the impact of targeted interventions tailored to identified risk factors to optimize surgical patient outcomes.
Keywords: Antimicrobial resistance; Multidrug-resistant organisms; Surgical site infection.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: This study was approved by the Medical Research Ethics Committee (MREC) of the University Malaya Medical Centre (UMMC) on 13 July 2020 (MREC-ID No.: 2020616-8769) in compliance with all applicable federal regulations governing the protection of human subjects. Extramural research review was conducted following the U.S. Navy Human Research Protection Program guidelines (HPRO.NAMRU2.2019.0009). All research activities conformed to the principles embodied in the Declaration of Helsinki. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.
References
-
- Fisichella L, Fenga D, Rosa MA. Surgical site infection in orthopaedic surgery: correlation between age, diabetes, smoke and surgical risk. Folia Med (Plovdiv). 2014;56(4):259–63. - PubMed
-
- Abu Hanifah Y. Post-operative surgical wound infection. Med J Malaysia. 1990;45(4):293–7. - PubMed
-
- Ban KA, Minei JP, Laronga C, Harbrecht BG, Jensen EH, Fry DE, et al. American college of surgeons and surgical infection society: surgical site infection guidelines, 2016 update. J Am Coll Surg. 2017;224(1):59–74. - PubMed
-
- Centers for Disease Control and Prevention. National Healthcare Safety Network. Surgical Site Infection Event (SSI). Atlanta (GA): Centers for Disease Control and Prevention; c2020 [updated January 2024; cited 2024 March 8]. Available from: https://www.cdc.gov/nhsn/pdfs/pscmanual/9pscssicurrent.pdf
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources